July 30, 2024Open Access

Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial

Key Points

Key points are not available for this paper at this time.

Abstract

Deprescribing of antihypertensive medications is recommended for some older patients with low blood pressure and frailty. The OPTiMISE trial showed that this deprescribing can be achieved with no differences in blood pressure control at 3 months compared with usual care. We aimed to examine effects of deprescribing on longer-term hospitalisation and mortality.

Read Full Paperexternally

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Sheppard et al. (Tue,) studied this question.

synapsesocial.com/papers/68e5e6e9b6db64358757b84a https://doi.org/https://doi.org/10.1016/s2666-7568(24)00131-4

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Demander à l'IA

Bookmark

View Full Paper